EUVIMEDOpdag EUVIMED
LeitlinieOpen access · CC BY-NC 4.0

Influence of Frailty and Life Expectancy on Guideline Adherence and Outcomes in Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Prospective Pilot Study

Alet J G Leus, Marjolijn S Haisma, Jorrit B Terra, Grigory Sidorenkov, Suzanne Festen, Boudewijn E C Plaat, György B Halmos, Emoke Racz

Dermatology · 2023 · 239 (1) · 148-157

DOI: 10.1159/000525974 ↗

At a glance

Leitlinie in Dermatology, published online on 2022-08-25. Written by Alet J G Leus and 7 co-authors. Institution: Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Major MEDLINE topics: Frailty, Carcinoma, Squamous Cell, Skin Neoplasms, Head and Neck Neoplasms. Cited 12 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cutaneous squamous cell carcinoma is the second most common malignancy of the skin, often occurring in older patients and in the head and neck area (cSCCHN). Age, life expectancy, and frailty are not taken into consideration by current guidelines.

Objectives

The objective of this study was to evaluate the influence of frailty and life expectancy on guideline deviation, treatment outcomes, and quality of life (QoL) after treatment in patients with cSCCHN.

Methods

Patients with cSCCHN were prospectively included. A geriatric assessment was performed, including the Geriatric 8 (G8), Groningen Frailty Indicator, and Timed Up and Go test (TUG). The Lee index was used to predict a limited life expectancy, and the Adult Comorbidity Evaluation-27 was used as a comorbidity index. QoL was assessed by the Basal and Squamous cell carcinoma Quality of Life (BaSQoL) questionnaire at three time points.

Results

Seventy-seven patients with cSCCHN were included. Frail patients had significantly more high-risk tumours. Guideline deviation occurred in 7.8% and was more common in patients who were frail (G8), with high-risk tumours (≥T2), with a limited life expectancy or an increased TUG. Guideline deviation did not lead more often to progression of disease in our study. No predictors for post-operative complications were found. BaSQoL subscores were very low at each time point and did not change significantly with time in the total group. Frail patients reported more fear of recurrence or new tumours 3 months after treatment, and less concern about other people’s skin 6 months after treatment, compared to non-frail patients. Complication rate, gender, or guideline deviation did not affect any subscale scores.

Conclusions

Assessment of frailty and life expectancy can guide physicians and patients in treatment decisions. Deviation from guidelines towards less aggressive treatment schedules can be considered in frail patients with a limited life expectancy, since it did not negatively affect short-term outcomes or QoL in patients with cSCCHN in our study. However, these results should be confirmed by other, larger prospective studies with a longer follow-up period.

Subjects

MeSH terms (MEDLINE)

FrailtyCarcinoma, Squamous CellSkin NeoplasmsHead and Neck NeoplasmsHumansAgedProspective StudiesQuality of LifePilot ProjectsSquamous Cell Carcinoma of Head and NeckGuideline AdherencePostural BalanceTime and Motion StudiesLife Expectancy

Author keywords

Cutaneous squamous cell carcinomaFrailtyGuideline adherenceLife expectancyQuality of life

Authors and institutions

  • Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Geriatric Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Cite

APA

Leus, A. J. G., Haisma, M. S., Terra, J. B., Sidorenkov, G., Festen, S., Plaat, B. E. C., Halmos, G. B., & Racz, E. (2023). Influence of Frailty and Life Expectancy on Guideline Adherence and Outcomes in Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Prospective Pilot Study. Dermatology, 239(1), 148-157. https://doi.org/10.1159/000525974

Vancouver

Leus AJG, Haisma MS, Terra JB, Sidorenkov G, Festen S, Plaat BEC, et al. Influence of Frailty and Life Expectancy on Guideline Adherence and Outcomes in Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Prospective Pilot Study. Dermatology. 2023;239(1):148-157. doi:10.1159/000525974

BibTeX
@article{Leus2023,
  author = {Leus, Alet J G and Haisma, Marjolijn S and Terra, Jorrit B and Sidorenkov, Grigory and Festen, Suzanne and Plaat, Boudewijn E C and Halmos, György B and Racz, Emoke},
  title = {Influence of Frailty and Life Expectancy on Guideline Adherence and Outcomes in Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Prospective Pilot Study},
  journal = {Dermatology},
  year = {2023},
  volume = {239},
  number = {1},
  pages = {148--157},
  doi = {10.1159/000525974}
}
Start for free →